WOODROW ADAM (VP & Chief Commercial Officer) sold 1.0% of their position (6.75K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $13.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/22/2022ACC: 0000904454-22-000655
Officer· VP & Chief Commercial Officer
Since Oct 2018
+15.75K
Net shares
Net buyer
$13.4K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
22.50K acquired · 6.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22.50K
Price / share
—
Trade value
—
% of position
3.5%
12/20/2022
635.53K→658.03K
Common Stock
Direct
Shares
−6.75K
Price / share
$1.99
Trade value
$13.43K
% of position
1.0%
12/21/2022
658.03K→651.28K
Total
Net shares
+15.75K
Net value
-$13.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2022 | A · Award | +22.50K | — | — | 3.5% | 635.53K | 658.03K |
| Common Stock Direct | 12/21/2022 | S · Sale | −6.75K | $1.99 | $13.43K | 1.0% | 658.03K | 651.28K |
| Total | +15.75K | -$13.43K | ||||||
Derivative Transactions0
No derivative transactions reported